Semax

Semax Peptide - Russian-Origin Nootropic Research Peptide

Semax is a seven-amino-acid peptide developed in Russia in the 1980s. It is a modified fragment of ACTH (the hormone that controls the stress response), but with a small three-amino-acid “tail” added to the end that does two things: it stops the peptide from acting on stress-hormone receptors, and it stops the body from breaking it down as quickly. The result is a nootropic peptide that crosses into the brain and stays there long enough to have an effect. Semax is approved in Russia for stroke and cognitive use, and is the peptide most researchers reach for when they want to study BDNF - the “fertilizer” protein that keeps brain cells healthy and connected.

Why Semax’s Design Matters

The interesting thing about Semax is what the small tail (Pro-Gly-Pro) changes. Without it, you’d basically have a short-lived ACTH fragment - it would activate stress receptors and disappear within minutes. With the tail added, the peptide stops binding those receptors entirely and instead triggers a fast rise in BDNF, the main growth factor for brain cells. That shift from “stress hormone fragment” to “brain growth factor trigger” is why Semax looks so different from its parent molecule in research.

Semax vs Selank - How the Two Russian Peptides Differ

Semax and Selank are the two most widely studied Russian research peptides. They come from the same lab tradition and both use the PGP stability tail, but they aim at different targets. Researchers typically pick one based on the endpoint they want to measure.

Semax is studied when the endpoint is alertness, memory, or neurorecovery. Selank is studied when the endpoint is calming or anxiety-related behavior. They are often paired in the same study design because they cover the cognitive and stress sides of brain research without duplicating each other.

Research Applications

Semax is used in studies examining:

• Neuroprotection in stroke and low-oxygen models
• Attention, learning, and memory in rodent behavioral tests
• How quickly BDNF rises after a single dose
• Anxiety-related behavior and stress hormone response
• Dopamine system changes relevant to attention research
• How the PGP tail affects peptide stability and brain penetration
• Comparative studies alongside N-Acetyl Semax Amidate (a longer-acting derivative)

Specifications

Storage & Handling

Unopened vials are kept at 2-8°C under standard cold-chain conditions and remain stable for 12+ months. Reconstitution parameters, solvent compatibility, and post-reconstitution stability for Semax are documented in the published peer-reviewed literature and standard peptide-chemistry references.

Reference Literature

Published clinical and preclinical Semax literature is available through PubMed, Google Scholar, and other peer-reviewed databases. WWP does not provide protocol design, dosing guidance, or administration parameters. Those decisions rest with the researcher and any applicable institutional review board.

Common Questions About Semax Research

What does Semax do in research models?

Published Semax research reports rapid BDNF upregulation in cortical and hippocampal brain tissue, increased NGF expression, modulation of dopamine transporter activity, and effects on serotonin metabolism. Behavioral studies report changes in attention, learning, and stress response. It is also studied in neuroprotection models for stroke and low-oxygen injury.

What is the difference between Semax and Selank?

Semax targets cognition, attention, and BDNF-driven neuroprotection. Selank targets anxiety and GABAergic calming. Both use the same PGP stability tail, but they are derived from different parent molecules (ACTH for Semax, tuftsin for Selank) and they are studied for different endpoints. Researchers often pair them to cover both sides of the cognition-stress axis in one model.

What is N-Acetyl Semax Amidate?

N-Acetyl Semax Amidate (NA-Semax, NASA) is a chemically modified version of Semax with an acetyl group on the N-terminus and an amide on the C-terminus. These two small modifications extend its half-life significantly, meaning it stays active longer per dose. It is studied as a longer-duration alternative to standard Semax in cognitive and neuroprotection research.

Is Semax legal to purchase as a research peptide?

Semax is not a controlled substance in the United States. It is not FDA approved for any medical use, and every vial WWP ships is sold strictly for laboratory and research use only, not for human consumption. Outside of Russia and Ukraine - where Semax is a prescription drug - it is not approved for clinical use anywhere.

How is Semax stored?

Unopened vials are stored at 2-8°C (refrigerator temperature) and stay stable for 12+ months. Once reconstituted with bacteriostatic water, the solution is kept at 2-8°C and used within 28-30 days.

Research Stacks

Semax is commonly paired in research settings with:

• Selank - Selank is a related Russian peptide aimed at calming and anxiety instead of alertness. Researchers pair the two to study the cognitive and stress sides of the brain at the same time.
• Cerebrolysin - Cerebrolysin is a mix of small neurotrophic peptides. Combining it with Semax creates a multi-pathway model for studying how different growth factors support brain recovery.
• DSIP - DSIP acts on sleep and stress. Pairing it with Semax lets researchers look at cognitive performance when sleep or stress load is changed.

Purity Guarantee

Every batch is ≥99% purity. Send us a COA from any independent test and we’ll issue store credit regardless of what it shows.